Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1625 of 5804
-
Heart transplant patients get new weapon against hidden artery damage
Disease control CompletedThe focus of this study is to test the safety and efficacy of the PCSK9 inhibitor, alirocumab when administered early after heart transplantation (HT).The main objective of this project is to test the safety and impact on cardiac allograft vasculopathy (CAV) of alirocumab when gi…
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Can intensive behavioral therapy boost social skills in young children with autism?
Symptom relief CompletedThe purpose of this study is to examine the effectiveness of pivotal response training (PRT) in an intensive center-based environment to treat social communication deficits in children with autism spectrum disorder (ASD).
Phase: NA • Sponsor: Stanford University • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Radiation-Free path for Low-Risk breast cancer patients?
Disease control OngoingFollowing breast-conserving surgery (BCS) for localized ductal carcinoma in situ (DCIS) of the breast, whole-breast irradiation (WBRT) is a standard of care, reducing the absolute rate of in-breast recurrences (IBR) by more than 15% at 10 years, from 28% without radiotherapy to 1…
Phase: NA • Sponsor: UNICANCER • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
Freezing hope: new study aims to protect fertility in transgender youth
Knowledge-focused OngoingThe goal of this study is to learn about fertility preservation in the gender-diverse community. The main objectives it aims to understand are to: 1. Optimize techniques for processing and cryopreserving testicular tissue. 2. Determine presence and number of germ cells (sperm pr…
Sponsor: University of Pittsburgh • Aim: Knowledge-focused
Last updated Jul 11, 2026 00:00 UTC
-
New radiation method aims to improve sarcoma surgery outcomes
Disease control Recruiting nowThe study is a randomized, open, prospective phase II study. The aim of the study is to evaluate the safety and feasibility of a hypofractionated, accelerated radiation approach based on the incidence of grade 3-5 NCI Common Terminology Criteria for Adverse Events (NCI-CTC-AE ) t…
Phase: NA • Sponsor: University Hospital Heidelberg • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Smart scans could spare lymphoma patients from extra chemo
Knowledge-focused Recruiting nowThe overarching goals of this study are to measure levels of circulating tumor DNA (ctDNA) in patients with early stage diffuse large B cell lymphoma (DLBCL), to assess the change in ctDNA during treatment in order to prospectively identify markers of treatment failure, and to us…
Phase: PHASE2 • Sponsor: University of Rochester • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New catheter procedure tightens leaky heart valves without surgery
Disease control CompletedThis research protocol tests a new technique and devices that we have developed to treat functional mitral valve regurgitation, called transcatheter mitral valve cerclage annuloplasty, otherwise known as "cerclage". Functional mitral valve regurgitation is a condition caused by d…
Phase: NA • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Weight-Loss drug semaglutide takes on PCOS in teen girls
Disease control CompletedGirls with obesity and polycystic ovarian syndrome will receive either glucagon like peptide-1 receptor agonist therapy or a dietary intervention for 12 weeks to decrease the metabolic syndrome, in particular to lower hepatic fat and improve insulin sensitivity.
Phase: PHASE2, PHASE3 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Could a brain steroid help veterans with PTSD?
Symptom relief CompletedThis study seeks to determine if pregnenolone can improve symptoms of PTSD and other symptoms that commonly occur with PTSD in Iraq/Afghanistan-era Veterans. The total study duration is 10 weeks. Eligible Veterans with PTSD will receive either pregnenolone or placebo throughout t…
Phase: PHASE2 • Sponsor: VA Office of Research and Development • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Stem cells boost knee cartilage healing in new trial
Disease control OngoingThe goal of this clinical trial is to learn if PRP and adipose-derived stem cells (AD-SVF) enhance healing after knee microfracture for chondral lesions. It will also learn about the safety of the procedure. The main questions it aims to answer are: Do PRP and AD-SVF get better …
Phase: PHASE4 • Sponsor: Università degli Studi dell'Aquila • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New colonoscope attachment aims to spot hidden polyps
Diagnosis CompletedThis study evaluates whether the use of a disposable colonoscope attachment, Endocuff Vision, can increase the detection of sessile serrated adenomas. Participating patients will be randomized to receive either standard colonoscopy or colonoscopy with the Endocuff Vision.
Phase: NA • Sponsor: University of California, Davis • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New chemo cocktail aims to fight esophageal cancer with fewer side effects
Disease control OngoingThis is a multi-center, open label, randomized phase II trial for patients with previously untreated metastatic or locally advanced esophagogastric cancer, using a pick the winner design to identify the best combination therapy in terms of progression free survival and neurotoxic…
Phase: PHASE2 • Sponsor: Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Could an arthritis drug tame pancreatitis inflammation?
Disease control Recruiting nowThis study evaluates the effectiveness and safety of infliximab in the treatment of acute pancreatitis in adults. A third of participants will receive one single dose of infliximab via infusion, another third will receive a higher dose of infliximab via infusion and the final thi…
Phase: PHASE2 • Sponsor: University of Liverpool • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug combo aims to tackle Hard-to-Treat cancers
Disease control TerminatedTo determine the recommended phase 2 dose (RP2D) of the combination of neratinib and sodium valproate when given to patients with advanced solid tumors. Then to explore the antitumor effects of the neratinib and sodium valproate combination in advanced solid tumors with attention…
Phase: PHASE1, PHASE2 • Sponsor: Virginia Commonwealth University • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
CT scans could make bypass surgery smarter
Disease control OngoingApply CT angiography, CT perfusion imaging and advanced image processing techniques to improve revascularization decision-making and surgical strategies in patients undergoing coronary artery bypass graft surgery.
Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
New hope for recurrent ovarian and endometrial cancers? drug tazemetostat under study
Disease control OngoingThis phase II trial studies how well tazemetostat works in treating patients with ovarian or endometrial cancer that has come back (recurrent). Chemotherapy drugs, such as tazemetostat, work in different ways to stop the growth of tumor cells, either by killing the cells, by stop…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Experimental drug combo targets brain cancer metabolism
Disease control OngoingThis phase 1b trial studies the side effects and best dose of telaglenastat in combination with radiation therapy and temozolomide in treating patients with IDH-mutated diffuse or anaplastic astrocytoma. Telaglenastat may stop the growth of tumor cells by blocking some of the enz…
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Blood test may spot hidden heart danger in sarcoidosis patients
Diagnosis Recruiting nowSarcoidosis is a multisystem granulomatous disease of unknown cause that can affect any organ in the body, including the heart. Granulomatous myocarditis can lead to ventricular dysfunction and ventricular arrhythmias causing significant morbidity and mortality. Immunosuppressive…
Phase: NA • Sponsor: Nabeel Hamzeh • Aim: Diagnosis
Last updated Jun 27, 2026 08:10 UTC
-
New radiation approach aims to shield memory during brain tumor treatment
Symptom relief Recruiting nowIn this proposal, the investigators introduce advanced diffusion and volumetric imaging techniques along with innovative, automated image parcellation methods to identify critical brain regions, incorporate into cognitive-sparing SRS, and analyze biomarkers of radiation response.…
Phase: PHASE2 • Sponsor: Jona Hattangadi-Gluth • Aim: Symptom relief
Last updated Jun 27, 2026 13:06 UTC
-
New radioactive drug targets childhood cancers that Won't quit
Disease control OngoingThe study evaluates CLR 131 in children, adolescents, and young adults with relapsed or refractory malignant solid tumors and lymphoma and recurrent or refractory malignant brain tumors for which there are no standard treatment options with curative potential.
Phase: PHASE1 • Sponsor: Cellectar Biosciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC